2025: Pfizer issues RFP for developing educational initiatives for to increase understanding of BCMA BsAbs for the treatment of relapsed/refractory multiple myeloma

Attachments

rfp17860-pfizer-issues-rfp-for-developing-educational-initiatives-for-to-increase-understanding-of-bcma-bsabs-for-the-treatment-of-relapsed-refractory-multiple-myeloma?utm_campaign=rfps%7C2025-05-23&utm_medium=email&utm_source=pnd